Changes in splanchnic energy and N metabolism were studied in sheep, prepared with vascular catheters across the portal-drained viscera (PDV) and the Liver, and maintained on supramaintenance intakes of either grass or grass+ barley pellets. The animals were challenged, on both diets, with 4 d intramesenteric vein infusions of NH4CI (25 pmol/min) plus NH,HCO, (at either 0 or 125 pmol/min). On the final day of each treatment the natural abundance NH,Cl was replaced with 15NH,Cl over a 10 h infusion while over the same period [l-13C]leucine was infused via a jugular vein. Measurements were made of blood flow plus mass transfers of NH,, urea, free amino acids and 0, across the PDV and liver. Enrichments of [14N15N]urea and [15N15N)urea plus [15N)glutamine, aspartate and glutamate were also monitored. Whole-body urea flux was determined by infusion of [14C]urea. At the end of the study the animals were infused for 3 h with l5NH4C1, killed and liver samples assayed for intracellular free amino acid enrichments and concentrations. Blood flows across the splanchnic region were unaffected by either diet or level of ammonium salt infusion. At the lower ammonium salt infusion there was a trend for greater absorption of NH, across the PDV (P < 010) with grass+ barley than with the grass diet, while removal of urea was unaltered. At the higher ammonium salt infusions there was a significantly greater appearance of NH, across the PDV and this exceeded the extra infused. Urea-N removal, however, was also elevated and by more than that required to account for the additional NH,. The PDV contributed 1P-28 % to whole-body 0, consumption and the liver 23-32 YO. Hepatic extraction of absorbed NH, was complete on all treatments and systemic pH remained constant. The fractions of urea-N apparently derived from NH, were similar on the grass (0.59-0.64) and grass + barley (0.64-0-67) diets. Hepatic production of urea agreed well with urea flux measurements. Between the two levels of ammonium salt infusion and within diets the additional NH, removed across the PDV was accounted for by the increased urea-N production. The [14N15N]: [l5NI5N] ratio of the urea produced was 97:3, while the enrichment of hepatic intracellular free aspartate was lower than that of [14N'5N]urea. Glutamine enrichments were 0.23-0.37 those of [14N'5N]urea, indicating a minor role for those hepatocytes (probably perivenous) which contain glutamine synthetase (EC 6.3.1.2). Leucine kinetics, either for the whole body or splanchnic tissues, were not different between diets or level of ammonium salt infusion, except for oxidation which was less on the grassfbarley ration. Amino acid concentrations were lower on the grass + barley diet but net PDV absorptions were similar. The pattern of essential amino acids absorbed into the PDV showed good agreement with the published composition of mixed rumen microbial protein.
sterile solutions which contained either low (L; 75 mM-NH,Cl; 25 pmol NH,+/min) or high (H; 75 mM-NH,Cl in 375 mM-NH,HCO,; 150 pmol NH:/min) amounts of ammonium salt dissolved in physiological saline (0.15 M-NaC1). Infusions covered 4 d and on the last day mass and isotope transfers across the splanchnic tissues were quantified. Within-diet comparisons were made 7 d apart. Two weeks were then allowed to change diets. Each animal was therefore studled on four occasions, GL, GH, GBL, GBH, with the design balanced in such a way that two animals started on each diet and with the order of NH, infusions either LHHL or HLLH. At the end of each dietary period animals spent 4 d in automated confinement respiration chambers (Blaxter et al. 1972 ) for measurement of whole-body gaseous exchange, but without any ammonium salt infusion; this provided a comparative base for the contribution of splanchnic tissue metabolism to whole-body 0, uptake.
Isotope infusions ['4CC]urea. In order to provide a comparison with urea production across the liver determined by the arterio-venous approach, urea entry rate was also quantified during a 54 h continuous infusion, into a jugular vein, of a [14C]urea solution (0.0037 MBq/g ; 5 g/h) prepared in sterile saline and containing 1 mM-unlabelled urea as carrier. Infusions were started 24 h after commencement of the ammonium salt administration with prior samples of urine, collected over 3 h, and blood (5 ml) taken to provide a 'background' sample. Over the last 4.5 h of [14C]urea infusion urine samples were collected over 1.5 h intervals while two 1 h integrated blood samples (each 5 ml) were taken from the aorta, hepatic portal and hepatic veins between 50 and 52 h. These samples were also used as natural abundance references for the stable-isotope infusions performed the next day. Both urine and blood were immediately processed as described later.
[ I -'Tlleucine and ['5N]ummonium salt. A sterile solution containing 0.5 g [I-13C]leucine (99 molar % ; Tracer Technology Ltd, Somerville, MA, USA) and 0.4 g sodium heparin in 200 g physiological saline was infused over 10 h (20 g/h) into the jugular vein on day 4 of the ammonium salt infusion. Over the same 10 h the ammonium salt infusate into the mesenteric vein was replaced with 200 g of a solution in which the NH,Cl was replaced with 15NH,C1 (98.4 molar % ; Europa Scientific, Crewe, Ches.) and which also contained 0 1 Msodium p-amino hippurate (pAH) and 0.05 M-sodium phosphate buffer, final pH 7.4. This was also infused at a rate of 20 g/h, so that the same rate of ammonium ion supply was maintained as for the previous 3 d but now 25 pmol/min of which was as 15NH,+.
Between hours 5 and 9 of stable isotope infusion, four integrated hourly blood samples, each of 12 ml, were collected from the aorta, hepatic portal and hepatic veins as described previously . Samples were immediately analysed for pH, pCO,, PO, and haemoglobin; two 1 g portions were then stored for bicarbonate enrichment. From the remainder both plasma and haemolysed blood, prepared with an equivolume of a solution containing 2-oxohexanoate and L-norleucine, were obtained as described previously . Three urine samples were also collected at 1.5 h intervals between hours 5 and 10 of this infusion.
At the end of the experiment animals were rested for at least 2 weeks and then infused via the mesenteric vein for 3 h with 70 rn~-l'NH,Cl (25 pmol "NH,+/min) and two 0.5 h integrated samples, taken from the same blood vessels as above, were collected over the last hour of infusion. Immediately following the last blood sample the animals were killed by an overdose of liquid anaesthetic and sections of liver rapidly excised, frozen in liquid N, and stored at -70".
Analyses
Preparation and measurement of blood pH, pCO,, PO,, haemoglobin (corrected for the spectral difference at 505 nm between human and sheep haemoglobin), bicarbonate enrichment, blood and plasma enrichments and concentrations of leucine and 4-methyl-2-oxopentanoate (MOP) were as described previously as was the determination of blood flow from pAH analyses. Plasma flow was calculated from blood flow and packed cell volume (PCV) determination. For enrichments (molar % excess; mpe) of [I5N"N]-and [14N15N]urea and 15N-labelled amino acids by gas-chromatography-massspectrometry (GCMS) the modification of the t-butyldimethylsilyl derivative preparation recommended by Patterson et al. (1993) was adopted. This allowed resolution of glutamine into [5-N] , total ([5-N] plus [2-N] ) and bis ([2,5-N,] ) labelled species. Liver free amino acid enrichments were determined in supernatant fractions from tissue homogenates prepared in 70 g/1 sulphosalicylic acid based on the procedure described by Calder & Smith (1988) .
Urea concentrations were determined on plasma and haemolysed blood by the diacetyloxime procedure while plasma NH, was determined immediately by a linked glutamate dehydrogenase (EC 1.4.1.2; GLDH) automated procedure as described previously (Lobley ef al. 1995) . Companion studies (G. D. Milano and G. E. Lobley, unpublished results) revealed that NH, concentrations in blood and plasma were equal and, because of technical problems associated with determination of the former, blood NH, transfers were calculated from the products of plasma concentrations and blood flows.
Amino acid concentrations in blood and plasma were determined on a pooled mixture prepared from the four samples obtained from each blood vessel within an infusion period. For hepatic portal and hepatic venous blood the samples were mixed in proportion to the respective blood (plasma) flows within each hour. Arterial blood was mixed on an equivolume basis ; this was because the hepatic arterial flow was obtained by difference between hepatic portal and hepatic venous flow and was small (less than 0.1 of hepatic venous flow) with considerable variance. Mixing by derived flow might therefore tend to introduce errors and/or sample bias. Amino acid analysis was by ion-exchange chromatography and ninhydrin detection as used previously . Monomethyllysine and I-methylhistidine co-chromatographed and the peak was quantified based on the ninhydrin colour yield of the former as this was the expected major contributor.
For [l*C]urea, blood and urine samples were deproteinized with 1.0 volume 100 g/1 TCA and duplicate 1 g portions of the supernatant fractions mixed in 10 ml Optima Gold (Canberra Packard, Pangbourne, Berks.). Radioactivity in all samples was determined using a Packard 1900 Tri-Carb liquid scintillation counter. Urea concentrations were determined in the TCA supernatant fractions by the automated diacetyloxime procedure. Four different preparative procedures were used for analysis of urine for [14N15N]-and [15N15N]urea. Urine was treated in one of the following ways: (1) reacted directly for GCMS analysis, (2) acidified to 100 g/1 TCA and the supernatant fraction analysed, (3) the acidified supernatant fraction adjusted to pH > 9 with NaOH and freeze-dried to remove NH, or (4) the urea isolated by ion-exchange chromatography (Jackson ef al. 1980) . The last three preparations were then treated with alkaline hypobromite and the amounts of N, gas produced with m/z of 28, 29 and 30 quantified by isotope-ratio mass spectrometry (IRMS).
Calculations and statistics Mass and isotope transfers were as detailed previously (Lobley ef al. 1995) and the mean values of the four 1 h collections used for data analyses. Urea entry rate ('pmol/min) was calculated from I/SRA,, where I is the rate of infusion of [14C]urea ($Ci/min) and SRA, the specific radioactivity (,uCi/,umol) of urea in either blood or urine.
The split-plot design of the experiment (with diet assigned to main plots) allowed standard ANOVA (Genstat 5 ; Rothamsted Experimental Station, Harpenden, Herts.) with separation of animal, diet, treatment and diet x treatment effects. Significances between treatments were assessed by use of the t statistic. For comparison of isotopic urea flux and hepatic release of urea, values were fitted to a linear regression equation where the latter was the independent variable and the constant set to zero.
RESULTS
All four sheep completed the trial but, as in the previous study , most of the distal mesenteric catheters eventually failed, in that blood could not be withdrawn (the index used for vessel patency) and, where necessary, experiments were finished with the proximal mesenteric catheter used for infusion. In one sheep this catheter was found to have entered the portal vein and this proved fortuitous as it provided a substitute when the normal portal vein catheter failed after two measurements. All other catheters remained patent throughout. Average live-weight gain over the 6 weeks of experiment was
kg/week.
Blood (plasma) flow and gaseous exchange (Table 1) At the higher ME intake used in the present study blood flow was greater than observed previously but was not significantly different between either diet or level of ammonium salt infusion. The contribution of hepatic artery to hepatic venous flow averaged 0.08 (range 0.05-0.10), a similar fraction to earlier observed values after the contribution of hepatic N-acetylation of pAH had been accounted . PCV values were not significantly different between treatments and, therefore, plasma flows showed similar trends to blood. The PCV ranged 0.23-0.32 between sheep.
Whole-body 0, consumption was slightly greater for the GB diet which may reflect the increased energy intake (predicted as G 11.5 MJ ME/d, GB 12.6 MJ ME/d). There were no significant differences with treatment for either portal-drained viscera (PDV) or hepatic 0, consumption although there was a tendency for elevated values during the H infusions, as observed previously . Overall, the splanchnic tissues contributed 0.434.58 of total 0, consumption, with a slightly higher proportion (0.524058) from the liver.
Blood pH, urea and ammonia concentrations ( Table 2) Arterial blood pH was unaffected by treatments and remained above pH 7.4; thus one criterion, avoidance of possible clinical acidosis, was attained. Similar pH values were observed between hepatic portal and hepatic venous blood; these were also unaltered by treatment and were 0.084.09 lower than the respective arterial pH (SED 0.006, P -= 0.001, 24 residual df).
Plasma NH, concentrations were greater (P < 0.001) in the hepatic portal vein than either the aorta or hepatic vein, which themselves were not significantly different. Only for hepatic portal plasma was there a significant increase in NH, concentration as a result of the H infusions.
Urea concentrations were identical between plasma and blood water (results not shown) for all samples. Treatment had no statistically significant effect on blood urea concentrations within sample sites, although there was a trend for values to be greater during the H infusions. There were significant differences, however, between all three sites (arterial 5.66 mM, hepatic portal 5.51 mM, hepatic 5.84 mM, SED 0.014, P < 0.001, 2 do. t By ANOVA; for complete data set 6 residual df except for whole-body oxygen consumption (3 residual df).
3 Largest SED value presented for information.
Each treatment value per sheep is the mean of four integrated hourly measurements. Ammonia and urea splanchnic bed transfers (Table 3) Both NH, appearance in the PDV (P < 0.001) and extraction by the liver (P c 0.001) were greater during the H infusions, but the absolute differences exceeded the extra NH, supplied.
In absolute terms the fraction of urea-N released into the blood from the liver which could be apparently accounted by NH, removal was similar for the GB diet (064467) and G (0-59-0-64) diet. The incremental changes in blood urea-N output:NH, uptake between L and H infusions were 1.13-1-17 for the two diets. Thus, only small amounts of non-NH, N were apparently required to support the hepatic detoxification of the exogenous NH, administration.
There was good agreement between urea fluxes measured in urine and blood, with the former preferred beCause the amount of radioactivity monitored was at least one order of magnitude greater, with appropriate gain in precision. Similarly, the relationship between urinary [14C]urea flux,and hepatic release into blood averaged 1.02 (SE 0.028; n 16).
Amino acid transfers (Tables 4 and 5 )
Arterial amino acid concentrations were not significantly affected by level of ammonium salt infusion but were by diet type, with elevated glycine and lowered valine, isoleucine, leucine, tyrosine, phenylalanine and monomethyllysine when animals were fed on ration GB compared with G. Similar differences were also observed for plasma and the two other sample sites monitored (results not shown). There were no significant differences between diets in the amount of any individual amino acid absorbed into the hepatic portal vein although there was a trend for increased net PDV appearance of non-essential, essential 
1) Also includes I-methylhistidine.
7 Values for plasma.
blood are not shown, but probabilities for diet effect are included.
Values are for diet effect. There were no significant effects for NH, level or diet x level interactions.
and branched-chain amino acids (BCAA) during H. Neither ornithine nor citrulline were fully resolved from other compounds during ion-exchange chromatography, while arginine in haemolysed blood was diminished due to arginase (EC 3.5.3.1) action. Therefore, net supply was estimated as the sum of essential and non-essential amino acids, with ornithine and citrulline omitted and arginine content assumed to be that in plasma. For the G diet PDV amino acid-N supply amounted to 0.40 and 0.59 of the N entry into the gastrointestinal tract (diet plus PDV urea extraction) at L and H with respective values for GB of 0.55 and 0.54. The pattern of absorbed amino acids showed good agreement with that reported for rumen microbial protein (RMP; Storm & Orskov, 1983) for the essential amino acids, based on leucine as reference (Fig. 1) . The data shown are based on transfers through plasma which has been shown to be the major site of carriage of absorbed amino acids (Heitmann & Bergman, 1980; Lobley et al. 1996) , but similar patterns were observed for blood (results not shown). Of the essential amino acids only lysine (K) showed any substantial deviation between the patterns of net PDV appearance and RMP. Whether the lower-than-theoretical appearance across the PDV represents a reduced availability from the gastrointestinal tract due to formation of s-aminolysyl complexes with other nutrients in TAAN, total amino acid-N, includes all amino acids tabulated in Table 4 ; NEAAN, non-essential amino acid-N excluding citrulline, ornithine and monomethyllysine; EAAN, essential amino acid-N ; BCAAN, branchedchain amino acid-N. the digesta remains to be elucidated. For the non-essential amino acids there was a marked deficit in apparent uptake of aspartate (D) and glutamate (E). These findings indicate that the net absorption of amino acids on both diets arises primarily from digestion in the small intestine of RMP and/or that dietary material which escapes rumen degradation is of similar composition. The net PDV appearances include material secreted from the pancreas and small intestine but subsequently reabsorbed, with the only main source not 'eliminated' through the arterio-venous measurements being pre-forestomach inflows (mouth, oesophagus etc.).
Removal of specific amino acids across the liver was unaffected by either diet or ammonium salt infusion, although the trend for increased net PDV appearance on diet GH was counterbalanced by a greater hepatic uptake. The mean fractional removal of net absorbed amino acids was 0.73 for both blood and plasma (results not shown). For some amino acids, however, notably the BCAA, the fractional extraction of that absorbed was low ( < 0.4) while others were removed almost entirely (e.g. histidine, phenylalanine, tyrosine, alanine, serine), as shown for plasma (Fig. 2) ; blood mean values were similar, but with greater variance. The fractional extractions of threonine, methionine and lysine were intermediate, but still considerable (0.7-0.8), while there was net output of glutamate, probably related to the uptake and hydrolysis of glutamine (results not shown).
Leucine kinetics (Table 6 ) Whole-body leucine flux was unaltered either by diet type or ammonium salt infusion (results not shown). Leucine movements to whole-body protein synthesis, calculated based on enrichments of either plasma leucine or MOP, were also uninfluenced by treatments.
Whole-body leucine oxidation was significantly lower on GB compared with G (P = 0.024) although fractional oxidations of the MOP-based flux were similar across treatments (range 0.23-0.27). The values for calculated protein synthesis across the splanchnic tissues varied depending on the choice of precursor but, based on similar considerations to the whole-body protein flux estimations, i.e. the enrichment of plasma leucine for the inflowing vascular pool, the PDV contributed 0.22-0.28 of total protein synthesis, with neither the absolute nor fractional proportion altered by treatment. Protein synthesis was lower in the liver and represented 0-13-0.19 of the whole-body values, with again no significant differences for diet or level of ammonium salt infusion. Leucine oxidation was divided approximately equally between the PDV and liver with a tendency for both the PDV and total splanchnic catabolism to be greater during the GH treatment. Overall, splanchnic tissues accounted for 0.33-0.57 of total leucine oxidation, with presumably much of the remainder due to peripheral tissue metabolism, notably muscle and fat (Harris et al. 1992 ).
l5N kinetics (Table 7)
Urea enrichments were identical in corresponding blood and plasma samples (results not shown). Enrichments of urea tended to be slightly greater in hepatic venous blood (plasma) than in either hepatic portal or arterial fluids, as observed previously , indicative of synthesis within the liver from I5N sources (results not shown). The differentials were less than in the earlier study, due to the lower enrichments of I5NH, obtained, and, in consequence, it was not possible to determine accurately the transfer of I5N into urea by use of arterio-venous calculations. Instead an indirect approach was adopted. Based on the assumptions that body water is 0.65 of live weight and that urea is distributed evenly throughout the aqueous pool then, for a 36 kg sheep (mean live weight at experimental mid-point), the body urea pool was 155 mmol and after 7 h of infusion this achieved a mean [14N15N]urea mpe of 3.0. Therefore, the amount of label incorporated into urea would be 4.7 mmol 15N while, in the same period, 10.5 mmol 15NH, was infused. When allowance is made for urinary elimination and gut recycling, approximately 0 . 8 4 9 of the administered 15N had entered ureagenesis. Enrichments of plasma NH, were not determined directly but, instead, were estimated from the mass flows in the hepatic portal vein and the rate of infusion of 15NH,CI, but 7. Relative enrichments* of 15N metabolites in sheep ofered either 1200 g grass pellets 600 g grass pellets plus 600 g barley pellets (GB) and infused with either 25 blood, averaged only 0-03 after 9 h of infusion, although the relative amounts of 15N would be twice this value. Similar relative distributions were also observed in urine samples analysed by IRMS procedures although the absolute enrichments were slightly lower (results not shown). These differences may relate to the time delay between appearance in blood and kidney filtration followed by bladder emptying. Alternatively, [14N1*N]urea may be produced within the kidney or urine by, for example, hydrolysis of arginine. Values obtained from the column-purified urea and alkali freeze-dried urine tended to be slightly lower than from acidified urine. The amount of label found in [15N,]glutamine was below the limits of GCMS detection (< 0.05 mpe). The combined enrichments of mono-labelled glutamine species, i.e. Of the free amino acids monitored from liver homogenates prepared after the terminal procedure, all exhibited lower enrichments than hepatic [l4Nl5N]urea, which also exceeded by 0.1 plasma urea mpe (Fig. 3) . Enrichments of homogenate aspartate and glutamate were greater than the corresponding amino acid in plasma but the situation with glutamine was less clear. This may be due to the relative amounts of periportal and perivenous material in the tissue samples analysed. Homogenate concentrations (mM) were: glutamate 14.1 (SE 2+7), aspartate 7-9 (SE 1-6), glycine 11.3 (SE 2.4) and serine 5 0 (SE 20), and these exceeded plasma concentrations in the hepatic portal vein by 20-100-fold.
D I S C U S S I O N

Mass N transfers
In general, urea production is lower, and whole-body N retention greater, on diets containing more concentrates (e.g. Reynolds et al. 1991 a). Several explanations have been offered for this phenomenon, including: sparing of amino acids as substrates for gluconeogenesis when propionate supply is enhanced; greater microbial protein synthesis due to more efficient capture of rumen NH,; suppression of hepatic ureagenesis through the inhibitory action of propionate on N-acetylglutamate synthesis and, thus, CPS activity (Stewart & Walser, 1980; Derr & Zieve, 1982; Garwacki et al. 1990) ; or that the lower demands on hepatic detoxification of NH, require less aspartate-N for the ornithine cycle to be provided from amino acids (Reynolds, 1992) . These last two considerations formed the conceptual basis of the current study. That extra NH, is usually absorbed with forage rations has been reported in several studies (e.g. Fitch et al. 1989; b). Fitch et al. (1989) also observed that the ratio of urea-N production:NH, removal by the liver was 2-8 and 1.3 for grass v. grass + barley rations respectively, although this was not supported in two other cattle trials where similar ratios were observed between high forage and high concentrate rations (1.2, Huntington, 1989 ; 1-6-1.8, Reynolds et al. 1991 b).
Overall, however, any reduced input, either in absolute or relative terms, to urea synthesis from non-NH, sources would potentially spare such nitrogenous metabolites for anabolic processes.
Direct links between hepatic NH, uptake and urea synthesis cannot be established from these studies, however, because the experimental designs involved alterations in either diet quality or quantity and thus more than one metabolite inflow was changed. To overcome the interpretative difficulties which ensue, recourse has been made to intravenous infusion of ammonium salts, and with both acute (Wilton et al. 1988 ) and chronic (Lobley et al. 1995) administrations of NH,C1 the extra-hepatic urea-N synthesis was double that of the N infused. This was also accompanied by an increase in leucine oxidation across the splanchnic bed.
The current study with sheep does not support several of the previous findings, with neither NH, absorption across the PDV, nor hepatic ureagenesis nor whole-body urea flux different between the GL and GBL diets. Such disparities between the various studies are difficult to reconcile but, setting aside species effects, may relate to differences in ruminal fermentation and/or N intake. Linear relationships have been fitted between PDV NH, flux and N intake (see Seal & Reynolds, 1993) , but with up to a 5-fold range of values at any specific intake. Similar large variance is observed also for the correlation between PDV a-amino-N flux and N intake (Seal & Reynolds, 1993) , indicative of the considerable variation that can occur in rumen fermentation and thus the amounts of the major Nproducts formed. For example, in the current study, NH, absorption was only 0.63-0-67 of amino acid-N PDV uptake, for both GL and GBL, whereas for the cattle studies this ratio was much greater (1.3-1.9, Reynolds et al. 1991b; 14-3-0, Huntington, 1989) . Comparatively, therefore, amino acids were the dominant absorbed N source in the sheep while NH, was the major N product of digestive metabolism in the cattle. In consequence, the metabolic demands between the various studies might be expected to differ considerably, as would the relative contribution of NH,-N to urea-N.
These differences in the pattern of absorbed N metabolites, when extended to liver metabolism, provide one explanation for the different responses between the current sheep data and both the cattle studies and the ovine data reported previously . The earlier sheep study offered lowered intakes, close to N equilibrium, where amino acid oxidation would link to maintenance of body N reserves and form part of the fundamental protein homeostasis. Furthermore, under those dietary conditions the absorbed NH,-N:amino acid-N ratio was 1-4, more similar to the cattle studies whereby NH, was the predominant N substrate, and this was raised to 2-1 with the exogenous NH, infusion. Under such conditions, NH,-N must be transferred to aspartate in order to provide the required equal inputs of N for arginosuccinate synthesis but if the actions of GLDH and aspartate aminotransferase (EC 2.6.1 . 1) are limited (by enzyme amount, 0x0-acid provision or mitochondria1 redox status) then alternative N sources for aspartate must be used, with amino acid-N as the favoured candidate. These would provide the circumstances in which incremental urea-N output would considerably exceed NH, input and lead to stimulation of leucine catabolism. In the current study the NH,-N: amino acid-N ratio available in the hepatic portal vein was much lower and, even when NH, was infused, did not rise above 0.8 and, at worst, hepatic extraction of amino acid-N was at least 088 of NH,-N removal. Thus, amino acids could usually have provided sufficient N for eventual transamination to aspartate, if required, and reduced the quantity of NH, required to react with GLDH. Under such circumstances it was not surprising to observe that hepatic free amino acid extraction and leucine oxidation were unchanged, both between diets G and GB and when the extra NH, was infused. These relationships between hepatic extraction of NH,-N : amino-N can be contrasted with the two cattle studies (Huntington, 1989; Reynolds et al. 1991 b) where the ratio ranged from 2.0 to 5.2, a clear imbalance in N inputs into the ornithine cycle compared with the current study. Thus, in the bovine trials, free (a) amino-N removal by the liver was larger on the rations with greater roughage (Huntington, 1989; Reynolds et al. 1991b ) and this may have been catabolized to maintain aspartate inputs for arginosuccinate synthesis with, in consequence, less free amino acid available for peripheral tissue protein gain .
The majority (0.85-0.90) of the additional urea synthesized between L and H infusions was extracted across the digestive tract and a fraction of this (0.22459) was returned to the circulation as NH, due to urease (EC 3.5.1.5) action of gut micro-organisms. Thus, NH, appearance across the PDV was augmented on the H infusions by more than the amount infused. For this reason the additional hepatic urea-N synthesis was 24-2.1 that of the exogenous NH,-N administered but less than 1.2 that actually removed by the liver. These calculations depend on accurate measurement of both blood flow and urea concentration differences but the excellent concordance between urea fluxes, monitored from either urine or blood samples and release across the liver, does support the reliability of the arterio-venous approach. Such comparisons also allay concerns about acute metabolic effects in response to the continuous blood-sampling procedure because the urea fluxes relate to integrated values over a prior 2 d period. These conclusions do presuppose, however, that urea flux is dominated by liver output and that production from other sites in the body, e.g. the kidney and erythrocyte (Covolo & West, 1947) , are minor, as is recycling of the labelled urea-C (Long et al. 1978 ).
An alternative explanation for the differences between the current and earlier ovine studies relate to acid-base balance because, previously, NH4C1 was infused and this lowered arterial pH by 0-08 units, whereas in the present study, with NH,HCO, as the predominant salt, pH was unaltered. In fasted humans, slightly greater pH decreases, following NH,C1 administration, caused an increase in whole-body leucine oxidation (Reaich et al. 1992) and, presumably, in catabolism of other amino acids. Such oxidation would provide extra bicarbonate and raise pH (Bean & Atkinson, 1984) .
[ I5N] transfers Overall, approximately 0.8-0-9 of the infused [15N] was estimated to appear in urea, which agrees well with the relative mass transfers observed. This also fits with the observation of Luo et al. (1995) with ovine hepatocytes, in which the majority of administered 15NH, appeared as urea under near-physiological incubation conditions. If NH,-N can enter both carbamoyl phosphate and aspartate the infusion of I5NH, should result in synthesis of [15N15N]~rea. Exactly how much is formed depends on the relative enrichments of mitochondria1 carbamoyl phosphate and the cytosolic aspartate pool, neither of which could be measured directly in the current study. If, however, it is assumed that these are in complete equilibrium and that, in both precursors, the proportions of substrate 14N and 15N are then p and q respectively (where p = 1 -q), the probabilities of the products [14N14N Table 6 ), a would be predicted at 5.7-3.8 %, which encompasses the calculated NH, enrichments presented to the liver. The fact that [15N15N]urea is produced indicates that NH,-N does enter both carbamoyl phosphate and aspartate but the extent of inflow into each metabolite cannot be determined without direct measurement of the enrichment of one of these ornithine cycle precursors. The combination, however, of the good agreement between the incremental mass transfers of NH, and urea-N, plus the concordance in the predicted portal vein NH, enrichment and the predicted value of a at complete equilibration, suggests near equal flows of NH, into the CPS and GLDH reactions.
This would agree with data from ovine hepatocytes in vitro where, in the absence of amino acids, urea output is closely quantified with NH, uptake and with ['5N'5N]urea as the predominant product (Luo et al. 1995) . Furthermore, in the hepatocytes the enrichments of intracellular aspartate and glutamate matched that of urea (Luo et al. 1995) , indicative of a rapid isotopic exchange between NH, and the dibasic amino acids through the actions of GLDH and aspartate aminotransferase, as has also been shown for rodent liver in vivo (Cooper et al. 1987) . That the intracellular enrichments of either aspartate or glutamate obtained at the end of the current study did not apparently confirm such an equilibrium can be accounted by intracellular compartmentalization in vivo. Cytosolic free aspartate and glutamate concentrations in ovine liver cells are 20-100-fold greater than in plasma (Demigne et al. 1991; current study), and 12-25-fold the net uptakes of NH,. The [15N]glutamate formed by GLDH action is restricted, however, to the small mitochondrion pool (Meijer et al. 1990 ) and does not mix readily with the large cytosolic pool, which consequently has a much lower enrichment. The aspartate formed within the mitochondrion by transamination of glutamate and oxaloacetate does enter the cytosol but spatial organization of enzymes close to the mitochondria1 outer membrane may direct this to formation of arginosuccinate and again prevent equilibration with cytosolic aspartate. Compartmentalization is a feature of the ornithine cycle, e.g. preferential use is made of ornithine from extra-mitochondria1 sources which does not mix with the intramitochondrial pool (Cohen et al. 1987) , while the arginine formed during ureagenesis remains separate from that transported into the cell or arising from protein degradation (Cheung et al. 1989) . To monitor true precursor enrichments would require, therefore, measurement of either carbamoyl phosphate or citrulline (for NH, inflows) and, by difference with arginosuccinate or urea isotopic activities, data obtained for aspartate. These approaches were outwith the current study in vivo.
Further differences between the current and the previous study were apparent from the rate of labelling of glutamine. Under both low and high NH, loading the enrichments of [5-'5N]glutamine were always less than 0.45 that in ['5N15N]~rea whereas previously they were similar and, thus, less "NH, was extracted by the perivenous hepatocytes. This may be due to the NH, load remaining within the extraction capacity of the periportal hepatocytes (which synthesize urea) or to a lesser demand on glutamine production within the perivenous cells to help balance acid-base status (see Haussinger et al. 1992) . Because glutamine reached a plateau within 4 h, the enrichment must reflect that of the precursor NH, pool(s) in the sites of de novo synthesis, which include the liver , lung, kidney and skeletal muscle (Heitmann & Bergman, 1978) . Recent observations under similar conditions have suggested that removal of "NH, from the portal vein can be almost complete across the ovine liver (Nieto et al. 1996) , with low enrichments of NH, (< 0.5 ape) in the hepatic vein and aorta, and thus the probable source of the labelled glutamine is the perivenous hepatocytes. Furthermore, the difference in isotopic activity between [16N15N]~rea and [5-15N]glutamine supports the concept of a zonal gradient of NH, enrichment between their respective sites of synthesis, the periportal and perivenous hepatocytes (Haussinger et al. 1992) .
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